June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
In-depth protein profiling and identification of tear fluid biomarkers in the glaucomatous eye
Author Affiliations & Notes
  • Natarajan Perumal
    Experimental Ophthalmology, University Medical Center Mainz, Mainz, Germany
  • Sebastian Funke
    Experimental Ophthalmology, University Medical Center Mainz, Mainz, Germany
  • Marco Kegel
    Experimental Ophthalmology, University Medical Center Mainz, Mainz, Germany
  • Maya Scieranski
    Experimental Ophthalmology, University Medical Center Mainz, Mainz, Germany
  • Norbert Pfeiffer
    Experimental Ophthalmology, University Medical Center Mainz, Mainz, Germany
  • Franz H Grus
    Experimental Ophthalmology, University Medical Center Mainz, Mainz, Germany
  • Footnotes
    Commercial Relationships Natarajan Perumal, None; Sebastian Funke, None; Marco Kegel, None; Maya Scieranski, None; Norbert Pfeiffer, None; Franz Grus, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3656. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Natarajan Perumal, Sebastian Funke, Marco Kegel, Maya Scieranski, Norbert Pfeiffer, Franz H Grus; In-depth protein profiling and identification of tear fluid biomarkers in the glaucomatous eye. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3656.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Glaucoma is a neurodegenerative ocular disease and one of the primary causes of blindness. Biomarker discovery in the tears of glaucomatous eye is still limited, which deters the development of improved diagnosis and subsequent prognosis of the disease. Therefore, the main objective of this study was to unravel the intricate human tear proteome regulation profiles of glaucoma patients and compared to that of dry eye and healthy donors employing the proteomics platform.

Methods: Eighty patients were recruited and subdivided into glaucoma patients (GLM; N=20), aqueous-deficient dry eye (DRYaq; N=20), a combination of the two diseases (GLM_DRYaq) and healthy subjects (CTRL; N=20). Tear samples were collected using Schirmer's strips. The tear proteome profiles were analyzed employing label-free mass spectrometry-based proteomics strategies for discovery and verification stages, with integration of state-of-the-art bioinformatics tool.

Results: Generally, there were only slight differences in the tear proteome of GLM compared to the CTRL group. Fifteen potential biomarkers for glaucoma were identified from the total of 205 tear proteins. Majority of these proteins involved in immune, inflammatory & apoptosis responses. Conversely, decrement of lacrimal gland-specific proteins and increment of inflammatory proteins were observed in DRYaq and GLM_DRYaq compared to the CTRL group.

Conclusions: The present study demonstrated that specific alterations in the tear proteome are associated with the glaucomatous eye. These outcomes, when extrapolated to clinical application, can provide invaluable hints on development of specific diagnostic tool for clinical tests and are of great importance for the prognosis of the disease.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×